Skip to search.
 TSX Up 0.10% TSX Ventures Down 0.25%

Eli Lilly and Company (LLY)

-NYSE
71.58 Down 0.82(1.13%) Apr 24, 4:04PM EDT
|After Hours : 71.69 Up 0.11 (0.15%) Apr 24, 5:34PM EDT
Add to Portfolio
Prev Close:72.40
Open:72.22
Bid:71.58 x 100
Ask:71.81 x 100
1y Target Est:77.59
Beta:0.38
Next Earnings Date:23-Jul-15LLY Earnings announcement
Day's Range:71.26 - 72.43
52wk Range:57.81 - 77.46
Volume:3,816,293
Avg Vol (3m):4,230,310
Market Cap:75.92B
P/E (ttm):32.10
EPS (ttm):2.23
Div & Yield:2.00 (2.80%)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
LLYDown 1.13%75.92B
GSKUp 0.60%112.07B
PFEDown 0.25%216.57B
SNYDown 0.02%135.32B

Key Statistics

Forward P/E (1 yr):20.28
P/S (ttm):3.91
Ex-Dividend Date:11-Feb-15

Analysts

Annual EPS Est (Dec-15) :3.16
Quarterly EPS Est (Jun-15) :0.74
Mean Recommendation*:2.3
PEG Ratio (5 yr expected):4.88

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Eli Lilly and Company discovers, develops, manufactures, and sells pharmaceutical products worldwide. It operates in two segments, Human Pharmaceutical Products and Animal Health products. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback